Cabazitaxel 99%CAS 183133-96-2 for Castration-Resistant Prostate Cancer

Short Description:

Cabazitaxel is a taxane anti-tumor API. Clinical trials have shown that it can also shrink tumors, slow the growth or spread of tumors, relieve symptoms of prostate cancer and improve the quality of life of patients. Cabazitaxel in combination with prednisone for the treatment of hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen. Hand Bio provides cabazitaxel 99% CAS 183133-96-2 for castration-resistant prostate cancer. For more details, please feel free to consult online.

Send email to us

Product Detail

Product Tags

Product Informations

Name: Cabazitaxel

CAS number: 183133-96-2

Chemical formula: C45H57NO14

Specifications: 99%

Color: white or off-white powder

Source: Semi-synthesized with 10-DAB

Type: APIs

Function

Clinical trials have shown that cabazitaxel can shrink tumors, slow the growth or spread of tumors, and relieve symptoms of prostate cancer.

Application areas

Pharmaceutical industry

The strength of Hande

Hande has a R&D team for many years. The team has applied for a number of patented inventions, and the process is seamless from laboratory to commercial mass production. The self-built GMP production base has passed the regulatory review of the US FDA, EU EDQM, China GMP, Japan PMDA, Australia TGA, South Korea, India, China Taiwan, Turkey, Russia, SGS, Dun & Bradstreet and other regulations. At the same time, the company is equipped with a research and development team, and has successively obtained a number of patents. QC testing room, highly realize product item testing.